Molecular biomarkers in prostate cancer tumorigenesis and clinical relevance-Reference-Cited by-同舟云学术

Molecular biomarkers in prostate cancer tumorigenesis and clinical relevance

Published:2024-02 Issue: Volume:194 Page:104232
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Alqualo Nathalia Oliveira,Campos-Fernandez Esther,Picolo Bianca Uliana,Ferreira Emanuelle Lorrayne,Henriques Laila Machado,Lorenti Sabrina,Moreira Danilo Caixeta,Simião Maria Paula Silva,Oliveira Luciana Beatriz Tiago,Alonso-Goulart Vivian^ORCID

Funder

FAPEMIG

CAPES

Instituto Nacional de Ciência e Tecnologia em Toxinas

Universidade Federal de Uberlândia

Instituto Nacional de Ciência e Tecnologia para Excitotoxicidade e Neuroproteção

INCT-TeraNano

CNPq

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference235 articles.

1. Role of a metastatic suppressor gene KAI1/CD82 in the diagnosis and prognosis of breast cancer;Al-Khater;Saudi J. Biol. Sci.,2021

2. Multifunctionality of prostatic acid phosphatase in prostate cancer pathogenesis;Alpert;Biosci. Rep.,2021

3. Somatic Mutations in Prostate Cancer: Closer to Personalized Medicine;Alvarez-Cubero;Mol. Diagn. Ther.,2017

4. The Eighth Edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging;Amin;CA Cancer J. Clin.,2017

5. The role of Nkx3.1 in cancers and stemness;Antao;Int J. Stem Cells 14:168–179,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Nanoparticle-Based Diagnostic and Treatment Options for Pancreatic Cancer;Cancers;2024-04-20